Johnson & Johnson

Johnson & Johnson as of Dec. 31, 2024

Portfolio Holdings for Johnson & Johnson

Johnson & Johnson holds 20 positions in its portfolio as reported in the December 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Protagonist Therapeutics (PTGX) 24.5 $95M 2.4M 38.60
CVRX (CVRX) 13.5 $52M 4.1M 12.67
Rapport Therapeutics (RAPP) 11.5 $44M 2.5M 17.74
Meiragtx Holdings (MGTX) 10.5 $40M 6.6M 6.09
Contineum Therapeutics Cl A (CTNM) 7.5 $29M 2.0M 14.65
Procept Biorobotics Corp (PRCT) 7.5 $29M 358k 80.52
Legend Biotech Corporation Sponsored Ads (LEGN) 6.9 $27M 815k 32.54
Neumora Therapeutics (NMRA) 5.1 $20M 1.8M 10.60
Xencor (XNCR) 4.5 $17M 748k 22.98
Nanobiotix Sponsored Ads (NBTX) 4.2 $16M 5.6M 2.87
Fate Therapeutics (FATE) 1.4 $5.6M 3.4M 1.65
Arrowhead Pharmaceuticals (ARWR) 1.2 $4.7M 248k 18.80
Rallybio Corp (RLYB) 0.9 $3.5M 3.6M 0.96
Vor Biopharma (VOR) 0.3 $1.2M 1.1M 1.11
Nano-X Imaging Ord Shs (NNOX) 0.3 $1.1M 159k 7.20
D Fluidigm Corp Del (LAB) 0.1 $546k 312k 1.75
Lyell Immunopharma 0.1 $527k 823k 0.64
Adicet Bio (ACET) 0.1 $351k 365k 0.96
Chardan Healthcare Acqu- Ord 0.0 $71k 97k 0.73
Senseonics Hldgs (SENS) 0.0 $29k 55k 0.52